|
|
Gene Symbol |
GPER1 |
|
Aliases |
CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR, mER |
|
Entrez Gene ID |
|
|
Gene Name |
G protein-coupled estrogen receptor 1 |
|
Chromosomal Location |
7p22.3 |
|
HGNC ID |
|
|
Summary |
This gene encodes a multi-pass membrane protein that localizes to the endoplasmic reticulum and a member of the G-protein coupled receptor 1 family. This receptor binds estrogen and activates multiple downstream signaling pathways, leading to stimulation of adenylate cyclase and an increase in cyclic AMP levels, while also promoting intracellular calcium mobilization and synthesis of phosphatidylinositol 3,4,5-trisphosphate in the nucleus. This protein therefore plays a role in the rapid nongenomic signaling events widely observed following stimulation of cells and tissues with estrogen. This receptor has been shown to play a role in diverse biological processes, including bone and nervous system development, metabolism, cognition, male fertility and uterine function. [provided by RefSeq, Aug 2017]
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0001934 |
Biological process |
Positive regulation of protein phosphorylation |
IDA |
20551055, 21427217 |
GO:0002695 |
Biological process |
Negative regulation of leukocyte activation |
IDA |
23285008 |
GO:0007186 |
Biological process |
G protein-coupled receptor signaling pathway |
IMP |
23840305 |
GO:0007189 |
Biological process |
Adenylate cyclase-activating G protein-coupled receptor signaling pathway |
IDA |
15539556 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IMP |
20551055 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IMP |
23840305 |
GO:0010629 |
Biological process |
Negative regulation of gene expression |
IMP |
23840305 |
GO:0010948 |
Biological process |
Negative regulation of cell cycle process |
IMP |
23840305 |
GO:0014068 |
Biological process |
Positive regulation of phosphatidylinositol 3-kinase signaling |
IDA |
15705806 |
GO:0030335 |
Biological process |
Positive regulation of cell migration |
IMP |
20551055 |
GO:0030518 |
Biological process |
Intracellular steroid hormone receptor signaling pathway |
IBA |
21873635 |
GO:0030518 |
Biological process |
Intracellular steroid hormone receptor signaling pathway |
IDA |
15705806 |
GO:0032962 |
Biological process |
Positive regulation of inositol trisphosphate biosynthetic process |
IDA |
15705806 |
GO:0043401 |
Biological process |
Steroid hormone mediated signaling pathway |
IDA |
19931550 |
GO:0045742 |
Biological process |
Positive regulation of epidermal growth factor receptor signaling pathway |
IDA |
15705806 |
GO:0045745 |
Biological process |
Positive regulation of G protein-coupled receptor signaling pathway |
IDA |
15539556 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
20551055 |
GO:0050728 |
Biological process |
Negative regulation of inflammatory response |
IDA |
23285008 |
GO:0051281 |
Biological process |
Positive regulation of release of sequestered calcium ion into cytosol |
IDA |
15705806 |
GO:0051898 |
Biological process |
Negative regulation of protein kinase B signaling |
IMP |
23840305 |
GO:0070373 |
Biological process |
Negative regulation of ERK1 and ERK2 cascade |
IMP |
23840305 |
GO:0070374 |
Biological process |
Positive regulation of ERK1 and ERK2 cascade |
IDA |
20551055, 21427217 |
GO:0070474 |
Biological process |
Positive regulation of uterine smooth muscle contraction |
IDA |
21427217 |
GO:0071356 |
Biological process |
Cellular response to tumor necrosis factor |
IDA |
23285008 |
GO:0071375 |
Biological process |
Cellular response to peptide hormone stimulus |
IDA |
21427217 |
GO:0071392 |
Biological process |
Cellular response to estradiol stimulus |
IBA |
21873635 |
GO:0071392 |
Biological process |
Cellular response to estradiol stimulus |
IDA |
15539556, 15705806, 19931550, 20551055, 21149639, 21427217, 21540189, 23285008 |
GO:1903078 |
Biological process |
Positive regulation of protein localization to plasma membrane |
IDA |
23674134 |
GO:1904706 |
Biological process |
Negative regulation of vascular smooth muscle cell proliferation |
IMP |
23840305 |
GO:2000724 |
Biological process |
Positive regulation of cardiac vascular smooth muscle cell differentiation |
IMP |
23840305 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
20551055, 23285008 |
GO:0005635 |
Cellular component |
Nuclear envelope |
IDA |
15705806 |
GO:0005769 |
Cellular component |
Early endosome |
IDA |
21540189 |
GO:0005783 |
Cellular component |
Endoplasmic reticulum |
IDA |
15705806, 21540189 |
GO:0005794 |
Cellular component |
Golgi apparatus |
IBA |
21873635 |
GO:0005794 |
Cellular component |
Golgi apparatus |
IDA |
15705806 |
GO:0005802 |
Cellular component |
Trans-Golgi network |
IDA |
21540189 |
GO:0005886 |
Cellular component |
Plasma membrane |
IDA |
15539556, 19931550, 21149639, 21427217, 21540189, 23674134 |
GO:0005886 |
Cellular component |
Plasma membrane |
IDA |
15705806 |
GO:0005887 |
Cellular component |
Integral component of plasma membrane |
TAS |
8920907 |
GO:0030659 |
Cellular component |
Cytoplasmic vesicle membrane |
IDA |
21540189 |
GO:0045095 |
Cellular component |
Keratin filament |
IDA |
21149639 |
GO:0048471 |
Cellular component |
Perinuclear region of cytoplasm |
IDA |
21540189 |
GO:0055037 |
Cellular component |
Recycling endosome |
IDA |
21540189 |
GO:0003682 |
Molecular function |
Chromatin binding |
IDA |
20551055 |
GO:0005496 |
Molecular function |
Steroid binding |
IDA |
15539556, 15705806 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
20551055, 21149639, 23674134 |
GO:0030284 |
Molecular function |
Estrogen receptor activity |
IBA |
21873635 |
GO:0030284 |
Molecular function |
Estrogen receptor activity |
IDA |
15539556, 15705806 |
GO:1990239 |
Molecular function |
Steroid hormone binding |
IDA |
19931550 |
|
Protein Information |
|
Protein Name |
G-protein coupled estrogen receptor 1, G protein-coupled receptor 30, IL8-related receptor DRY12, chemoattractant receptor-like 2, chemokine receptor-like 2, constitutively expressed peptide-like receptor, flow-induced endothelial G-protein coupled receptor 1, heptahelix receptor, lymphocyte-derived G-protein coupled receptor, membrane estrogen receptor |
|
Function |
G-protein coupled estrogen receptor that binds to 17-beta-estradiol (E2) with high affinity, leading to rapid and transient activation of numerous intracellular signaling pathways. Stimulates cAMP production, calcium mobilization and tyrosine kinase Src inducing the release of heparin-bound epidermal growth factor (HB-EGF) and subsequent transactivation of the epidermal growth factor receptor (EGFR), activating downstream signaling pathways such as PI3K/Akt and ERK/MAPK. Mediates pleiotropic functions among others in the cardiovascular, endocrine, reproductive, immune and central nervous systems. Has a role in cardioprotection by reducing cardiac hypertrophy and perivascular fibrosis in a RAMP3-dependent manner. Regulates arterial blood pressure by stimulating vasodilation and reducing vascular smooth muscle and microvascular endothelial cell proliferation. Plays a role in blood glucose homeostasis contributing to the insulin secretion response by pancreatic beta cells. Triggers mitochondrial apoptosis during pachytene spermatocyte differentiation. Stimulates uterine epithelial cell proliferation. Enhances uterine contractility in response to oxytocin. Contributes to thymic atrophy by inducing apoptosis. Attenuates TNF-mediated endothelial expression of leukocyte adhesion molecules. Promotes neuritogenesis in developing hippocampal neurons. Plays a role in acute neuroprotection against NMDA-induced excitotoxic neuronal death. Increases firing activity and intracellular calcium oscillations in luteinizing hormone-releasing hormone (LHRH) neurons. Inhibits early osteoblast proliferation at growth plate during skeletal development. Inhibits mature adipocyte differentiation and lipid accumulation. Involved in the recruitment of beta-arrestin 2 ARRB2 at the plasma membrane in epithelial cells. Functions also as a receptor for aldosterone mediating rapid regulation of vascular contractibility through the PI3K/ERK signaling pathway. Involved in cancer progression regulation. Stimulates cancer-associated fibroblast (CAF) proliferation by a rapid genomic response through the EGFR/ERK transduction pathway. Associated with EGFR, may act as a transcription factor activating growth regulatory genes (c-fos, cyclin D1). Promotes integrin alpha-5/beta-1 and fibronectin (FN) matrix assembly in breast cancer cells. |
|
|
UniProt |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000365777 |
P42898 |
P42898 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Multiple congenital anomalies |
|
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Breast Cancer |
|
|
References |
|
|
Wang Aiming, Ji Lijuan, Shang Wei, Li Min, Chen Lei, White Richard E, Han Guichun |
Department of Obstetrics and Gynecology, Navy General Hospital, Beijing 10048, PRC. one_army@sohu.com |
Gynecol Endocrinol. 2011 Apr;27(4):251-5. doi: 10.3109/09513590.2010.487584. Epub |
Abstract
Women with polycystic ovary syndrome (PCOS) exhibit a lower pregnancy rate, which may be related to decreased estrogen receptor (ER) expression or endometrial receptivity. We measured expression of ERalpha, ERbeta and the novel G protein-coupled ER (GPR30) in endometrium during window of implantation (WOI) in PCOS patients. Fifteen Chinese women with PCOS were compared to 15 normal subjects. Serial trans-vaginal ultrasonic scanner (TVUS) examinations detected follicular development, and endometrial thickness and pattern were assessed via TVUS on the day of ovulation. GPR30 expression was detected in the cytoplasm of endometrial epithelial cells, and was significantly lower in the PCOS group (p < 0.05). ERalpha and ERbeta expression was lower in the PCOS group, and was detected mainly in the nucleus of endometrial epithelial cells. There was no significant difference in endometrium thickness (p > 0.05), but there was a significant difference in the ultrasonic pattern (p < 0.05). Endometrial expression of GPR30, ERalpha and ERbeta was decreased during WOI in PCOS patients, and was accompanied by poor endometrial receptivity, low pregnancy rate and higher spontaneous abortions. We propose that restored receptor expression might improve endometrial receptivity and help lower infertility associated with PCOS. |
|
|
|